Cargando…
Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond
Generalised pustular psoriasis (GPP), a severe neutrophilic skin disease characterised by the sudden and widespread eruption of superficial sterile pustules, remains a challenging disease with limited treatment options. The recent discovery of genetic mutations associated with GPP and advances in un...
Autor principal: | Sugiura, Kazumitsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850521/ https://www.ncbi.nlm.nih.gov/pubmed/35060076 http://dx.doi.org/10.1007/s13555-021-00677-8 |
Ejemplares similares
-
Acrodermatitis Continua of Hallopeau Evolving into Generalised Pustular Psoriasis
por: Ranugha, Poovanur SS, et al.
Publicado: (2013) -
Tozinameran: Exacerbations of generalised pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris: 3 case reports
Publicado: (2022) -
Anti CD-6 Monoclonal Antibodies in the Management of Generalised Pustular Psoriasis
por: Kura, Mahendra M., et al.
Publicado: (2022) -
Elderly-Onset Generalized Pustular Psoriasis without a Previous History of Psoriasis Vulgaris
por: Aizu, Takayuki, et al.
Publicado: (2015) -
Generalized pustular psoriasis with a novel mutation of interleukin-36 receptor antagonist, responding to methotrexate
por: Teoh, Yee-Leng, et al.
Publicado: (2015)